| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
39,413 |
29,497 |
$1.15M |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,569 |
7,879 |
$374K |
| 90832 |
Psychotherapy, 30 minutes with patient |
6,291 |
4,402 |
$235K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,884 |
1,396 |
$39K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
3,094 |
2,846 |
$30K |
| 90837 |
Psychotherapy, 53 minutes with patient |
424 |
326 |
$29K |
| 99308 |
Subsequent nursing facility care, per day, straightforward |
1,233 |
1,163 |
$22K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,513 |
1,428 |
$21K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
202 |
185 |
$10K |
| 99490 |
Ccm add 20min |
250 |
239 |
$6K |
| G0511 |
Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month |
892 |
798 |
$5K |
| 90834 |
Psychotherapy, 45 minutes with patient |
92 |
80 |
$4K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
318 |
215 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
313 |
262 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
123 |
106 |
$3K |
| 90791 |
Psychiatric diagnostic evaluation |
42 |
37 |
$3K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
45 |
43 |
$2K |
| 99173 |
|
96 |
89 |
$2K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
127 |
119 |
$2K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
15 |
12 |
$932.10 |
| 90658 |
|
70 |
68 |
$832.40 |
| 90688 |
|
46 |
45 |
$589.13 |
| 0012A |
|
12 |
12 |
$420.00 |
| 90833 |
Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) |
42 |
35 |
$405.98 |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
608 |
538 |
$261.55 |
| 81025 |
|
40 |
36 |
$203.37 |
| 82962 |
|
102 |
91 |
$146.95 |
| 80305 |
|
14 |
12 |
$129.74 |
| 81003 |
|
210 |
189 |
$79.67 |
| 99051 |
|
30 |
30 |
$22.50 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
13 |
12 |
$8.90 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
171 |
146 |
$0.54 |
| 91301 |
|
47 |
43 |
$0.23 |
| 3008F |
|
8,455 |
6,478 |
$0.05 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
348 |
321 |
$0.00 |
| 1000F |
|
131 |
125 |
$0.00 |
| 3074F |
|
14 |
13 |
$0.00 |
| 1036F |
|
56 |
50 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
15 |
12 |
$0.00 |
| 1030F |
|
13 |
12 |
$0.00 |
| 3079F |
|
14 |
12 |
$0.00 |
| 1034F |
|
14 |
13 |
$0.00 |
| 3725F |
|
42 |
40 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
15 |
12 |
$0.00 |
| 3078F |
|
33 |
32 |
$0.00 |
| 3077F |
|
17 |
13 |
$0.00 |